Testing effectiveness (Phase 2)Looking for participantsNCT06891417
What this trial is testing
Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years
Who this might be right for
Chlamydia Trachomatis Immunization
Sanofi 1,560